Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial-Reference-Cited by-全球学者库

Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial

Published:2021-10-05 Issue:2 Volume:196 Page:424-432
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ying Lianghong¹²^ORCID,Wang Jing¹³,Li Juan¹⁴,Teng Jianzhen¹,Zhang Xiaofeng¹⁵,Ullah Inam¹,Samee Abdus¹,Xu Ke¹⁶,Chen Jun¹,Xu Lei¹,Zhu Hui¹,Li Jimin¹,Yang Lu¹,Wang Fei¹,Fan Yuansheng¹,Zhang Jing¹,Lu Yi¹,Gong Xiaoxuan¹,Shi Lu¹,Eikelboom John W.⁷⁸,Li Chunjian¹^ORCID

Affiliation:

1. Department of Cardiology the First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China

2. Department of Cardiology the Affiliated Huai’an Hospital of Xuzhou Medical University Huai’an Second People’s Hospital Huai’an Jiangsu China

3. Department of Cardiology the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University Huai'an Jiangsu China

4. Cardiovascular Center the Second Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China

5. Department of Cardiology the Second Hospital of Nanjing Nanjing University of Chinese Medicine Nanjing Jiangsu China

6. Department of Cardiology Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

7. Department of Medicine McMaster University Hamilton Ontario Canada

8. Thrombosis Service Hamilton General Hospital Hamilton Ontario Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17847

Reference42 articles.

1. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

2. Pharmacogenetics in Cardiovascular Antithrombotic Therapy

3. Prevalence of poor biological response to clopidogrel

4. Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

5. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design;Thrombosis and Haemostasis;2023-08-07

2. Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous design;2023-05-29

3. Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study;Frontiers in Pharmacology;2022-09-08

4. Simultaneous determination of clopidogrel, 2-oxo-clopidogrel, and the thiol metabolite of clopidogrel in human plasma by LC-MS/MS;The Journal of Biomedical Research;2022

5. High on‐treatment platelet reactivity—an OPTIMAl solution, or a better solution?;British Journal of Haematology;2021-11-03